<?xml version="1.0" encoding="UTF-8"?>
<results title="plantparts">
 <result pre="clinical study to determine the efficacy of a novel fenugreek" exact="seed" post="( Trigonella foenum-graecum) extract (Fenfuro™) in patients with type"/>
 <result pre="spectrum safety and efficacy of Fenfuro, a novel T. foenum-graecum" exact="seed" post="extract enriched in furostanolic saponins, in type 2 diabetes"/>
 <result pre="efficacious in ameliorating the symptoms of T2D in humans. fenugreek" exact="seed" post="extract (Fenfuro) type 2 diabetes (T2D) blood pressure blood"/>
 <result pre="studies revealed the broad-spectrum safety and anti-diabetic efficacy of fenugreek" exact="seed" post="extract ( 28, 29). In the present study, we"/>
 <result pre="study, we assessed the efficacy of a novel, patented fenugreek" exact="seed" post="extract enriched in furostanolic saponins (Fenfuro), to determine its"/>
 <result pre="of 90 consecutive days. Materials and methods Novel Trigonella foenum-graecum" exact="seed" post="extract (Fenfuro) A patented T. foenum-graecum seed extract (Fenfuro™,"/>
 <result pre="Novel Trigonella foenum-graecum seed extract (Fenfuro) A patented T. foenum-graecum" exact="seed" post="extract (Fenfuro™, Batch No F0413, Mfg Date April 2013,"/>
 <result pre="placebo-controlled, double-blind, add-on clinical study entitled ‘Clinical evaluation of fenugreek" exact="seed" post="extract in patients with T2D: an add-on study’ (Protocol"/>
 <result pre="of intolerance or hypersensitivity to sulfonylurea or metformin or fenugreek" exact="seed" post="extract Subjects were strictly instructed to consume a prescribed"/>
 <result pre="mean±SD; ns, not significant. Discussion The largest producer of fenugreek" exact="seed" post="is India, and the seeds, leaves, and whole plant"/>
 <result pre="of fenugreek seed is India, and the seeds, leaves, and" exact="whole plant" post="are widely used both in fresh and dried forms"/>
 <result pre="also becoming popular in the Western world as a medicinal" exact="herb" post="or as a spice ( 32, 33). Fenugreek leaves"/>
 <result pre="studies were conducted in rats using a novel, patented, fenugreek" exact="seed" post="extract (Fenfuro) that is approximately 40% furostanolic saponins. Fenugreek"/>
 <result pre="35, 37, 38). Earlier studies in animals demonstrated that fenugreek" exact="seed" post="extract has the potential to slow the enzymatic digestion"/>
 <result pre="40) have shown that two different doses of defatted fenugreek" exact="seed" post="powder (25 or 50 g/day) significantly lower serum cholesterol"/>
 <result pre="similar controlled trial found that taking 2.5 g of fenugreek" exact="seed" post="twice a day for 3 months reduced blood glucose"/>
 <result pre="study in subjects with T2D used 1 g of fenugreek" exact="seed" post="extract/day over a period of 2 months and found"/>
 <result pre="levels ( 33, 40). Another randomized trial demonstrated that fenugreek" exact="seed" post="extract (100 g/day) lowers elevated blood glucose, TG, and"/>
 <result pre="Fenfuro (US Patent 8,754,205B2 17 Jun 2014, standardized Trigonella foenum-graecum" exact="seed" post="extract enriched in approximately 40% furostanolic saponins, dose: 500"/>
 <result pre="evaluation of a novel, patented anti-diabetic extract of Trigonella foenum-graecum" exact="seed" post="extract (Fenfuro) Toxicol Mech Methods 2014 24 7 495"/>
 <result pre="O Bagchi D Swaroop A et al. T rigonella foenum-graecum" exact="seed" post="extract (Fenfuro™) inhibits diet-induced insulin resistance and hepatic fat"/>
 <result pre="12469212 33 Elujoba AA Hardman R Saponin-hydrolyzing enzymes from fenugreek" exact="seed" post="Fitoterapia 1987 58 197 9 34 Bordia A Verma"/>
 <result pre="42 Neha S Anand K Sunanda P Administration of fenugreek" exact="seed" post="extract produces better effects in the glibenclamide-induced inhibition of"/>
</results>
